China Pilots Scheme To Halve IND Review Time For Innovative Drugs

 
• By Dexter Jie Yan
  
shorten time
China looks to cut the IND review time for innovative drugs to 30 working days in a new pilot scheme. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from China

More from Asia